{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:35:55Z","timestamp":1777840555552,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00228-021-03175-0","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T04:02:51Z","timestamp":1624593771000},"page":"1147-1156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Research on Beers Criteria and STOPP\/START Criteria based on the FDA FAERS database"],"prefix":"10.1007","volume":"77","author":[{"given":"Qianqian","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xishi","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4343-3151","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"3175_CR1","doi-asserted-by":"publisher","unstructured":"Wang T-C, Ku P-J, Lu H-L et al (2019) Association between potentially inappropriate medication use and chronic diseases in the elderly. Int J\u00a0Environ Res Public Health 16(12).\u00a0https:\/\/doi.org\/10.3390\/ijerph16122189","DOI":"10.3390\/ijerph16122189"},{"issue":"10","key":"3175_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.2165\/00002512-200623100-00005","volume":"23","author":"SS Egger","year":"2006","unstructured":"Egger SS, Bachmann A, Hubmann N et al (2006) Prevalence of potentially inappropriate medication use in elderly patients - comparison between general medical and geriatric wards. Drugs Aging 23(10):823\u2013837. https:\/\/doi.org\/10.2165\/00002512-200623100-00005","journal-title":"Drugs Aging"},{"issue":"4","key":"3175_CR3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"DM Fick","year":"2019","unstructured":"Fick DM, Semla TP, Steinman M et al (2019) American Geriatrics Society 2019 updated AGS Beers Criteria (R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67(4):674\u2013694. https:\/\/doi.org\/10.1111\/jgs.15767","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"3175_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/ageing\/afx178","volume":"47","author":"D O' Mahony","year":"2018","unstructured":"O\u2019 Mahony D, O\u2019 Sullivan D, Byrne S et al (2018) STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2 (vol 44, pg 213, 2015). Age Ageing 47(3):489\u2013489. https:\/\/doi.org\/10.1093\/ageing\/afx178","journal-title":"Age Ageing"},{"issue":"9","key":"3175_CR5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jash.2016.06.030","volume":"10","author":"WS Aronow","year":"2011","unstructured":"Aronow WS, Fleg JL, Pepine CJ et al (2016) ACCF\/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (vol 5, pg 259,2011). J Am Soc Hypertens 10(9):752\u2013752. https:\/\/doi.org\/10.1016\/j.jash.2016.06.030","journal-title":"J Am Soc Hypertens"},{"issue":"5","key":"3175_CR6","first-page":"477","volume":"170","author":"JC Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO et al (2010) Meta-analysis of the impact of 9 medication classes on falls in elderly persons (vol 169, pg 1952,2009). Arch Intern Med 170(5):477-U487","journal-title":"Arch Intern Med"},{"issue":"2","key":"3175_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00198-012-2053-3","volume":"24","author":"SD Berry","year":"2013","unstructured":"Berry SD, Zhu Y, Choi H et al (2013) Diuretic initiation and the acute risk of hip fracture. Osteoporos Int 24(2):689\u2013695. https:\/\/doi.org\/10.1007\/s00198-012-2053-3","journal-title":"Osteoporos Int"},{"issue":"8","key":"3175_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/pds.2176","volume":"20","author":"J Gribbin","year":"2011","unstructured":"Gribbin J, Hubbard R, Gladman J et al (2011) Risk of falls associated with antihypertensive medication: self-controlled case series. Pharmacoepidemiol Drug Saf 20(8):879\u2013884. https:\/\/doi.org\/10.1002\/pds.2176","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"3175_CR9","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamainternmed.2013.14764","volume":"174","author":"ME Tinetti","year":"2014","unstructured":"Tinetti ME, Han L, Lee DSH et al (2014) Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med 174(4):588\u2013595. https:\/\/doi.org\/10.1001\/jamainternmed.2013.14764","journal-title":"JAMA Intern Med"},{"issue":"8","key":"3175_CR10","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/jgs.12925","volume":"62","author":"ML Callisaya","year":"2014","unstructured":"Callisaya ML, Sharman JE, Close J et al (2014) Greater daily defined dose of antihypertensive medication increases the risk of falls in older people-a population-based study. J Am Geriatr Soc 62(8):1527\u20131533. https:\/\/doi.org\/10.1111\/jgs.12925","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"3175_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1590\/S1020-49892006000700014","volume":"20","author":"S Rosenfeld","year":"2006","unstructured":"Rosenfeld S (2006) Medication as a risk factor for falls in older women in Brazil (vol 13, pg 369, 2003). Revista Panamericana De Salud Publica-Pan American Journal of Public Health 20(1):8\u20138","journal-title":"Revista Panamericana De Salud Publica-Pan American Journal of Public Health"},{"issue":"10082","key":"3175_CR12","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/s0140-6736(17)31211-4","volume":"389","author":"T Tanimoto","year":"2017","unstructured":"Tanimoto T, Tsuda K, Kurokawa T et al (2017) Essential medicines for universal health coverage. Lancet 389(10082):1880\u20131881. https:\/\/doi.org\/10.1016\/s0140-6736(17)31211-4","journal-title":"Lancet"},{"issue":"6","key":"3175_CR13","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00228-019-02628-x","volume":"75","author":"S Schiek","year":"2019","unstructured":"Schiek S, Hildebrandt K, Zube O et al (2019) Fall-risk-increasing adverse reactions-is there value in easily accessible drug information? A case-control study. Eur J Clin Pharmacol 75(6):849\u2013857. https:\/\/doi.org\/10.1007\/s00228-019-02628-x","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3175_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40264-019-00899-y","volume":"43","author":"U Vogel","year":"2020","unstructured":"Vogel U, van Stekelenborg J, Dreyfus B et al (2020) Investigating overlap in signals from EVDAS, FAERS, and VigiBase (R). Drug Saf 43(4):351\u2013362. https:\/\/doi.org\/10.1007\/s40264-019-00899-y","journal-title":"Drug Saf"},{"issue":"7","key":"3175_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, Tamon A, Kadoyama K et al (2013) Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 10(7):796\u2013803. https:\/\/doi.org\/10.7150\/ijms.6048","journal-title":"Int J Med Sci"},{"issue":"7","key":"3175_CR16","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ggi.12359","volume":"15","author":"M-H Chiu","year":"2015","unstructured":"Chiu M-H, Lee H-D, Hwang H-F et al (2015) Medication use and fall-risk assessment for falls in an acute care hospital. Geriatr Gerontol Int 15(7):856\u2013863. https:\/\/doi.org\/10.1111\/ggi.12359","journal-title":"Geriatr Gerontol Int"},{"issue":"2","key":"3175_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.32614\/rj-2017-063","volume":"9","author":"T Canida","year":"2017","unstructured":"Canida T, Ihrie J (2017) openEBGM: an R implementation of the Gamma-Poisson Shrinker data mining model. R Journal 9(2):499\u2013519. https:\/\/doi.org\/10.32614\/rj-2017-063","journal-title":"R Journal"},{"issue":"6","key":"3175_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7150\/ijms.4549","volume":"9","author":"T Tamura","year":"2012","unstructured":"Tamura T, Sakaeda T, Kadoyama K et al (2012) Aspirin- and clopidogrel-associated bleeding complications: data mining of the public version of the FDA adverse event reporting system. AERS International Journal of Medical Sciences 9(6):441\u2013446. https:\/\/doi.org\/10.7150\/ijms.4549","journal-title":"AERS International Journal of Medical Sciences"},{"issue":"2","key":"3175_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/pds.1695","volume":"18","author":"X Ye","year":"2009","unstructured":"Ye X, Fu Z, Wang H et al (2009) A computerized system for signal detection in spontaneous reporting system of Shanghai China. Pharmacoepidemiol Drug Saf 18(2):154\u2013158. https:\/\/doi.org\/10.1002\/pds.1695","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3175_CR20","doi-asserted-by":"publisher","unstructured":"Kadoyama K, Kuwahara A, Yamamori M et al (2011) Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS. J\u00a0Exp Clin Cancer Res\u00a030.\u00a0https:\/\/doi.org\/10.1186\/1756-9966-30-93","DOI":"10.1186\/1756-9966-30-93"},{"issue":"6","key":"3175_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/ageing\/20.6.455","volume":"20","author":"RG Cumming","year":"1991","unstructured":"Cumming RG, Miller JP, Kelsey JL et al (1991) Medications and multiple falls in elderly people: the St Louis OASIS study. Age Ageing 20(6):455\u2013461. https:\/\/doi.org\/10.1093\/ageing\/20.6.455","journal-title":"Age Ageing"},{"key":"3175_CR22","doi-asserted-by":"publisher","unstructured":"Hatahira H, Hasegawa S, Sasaoka S et al (2018) Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database. J Pharm Health Care Sci 4.\u00a0https:\/\/doi.org\/10.1186\/s40780-018-0129-8","DOI":"10.1186\/s40780-018-0129-8"},{"issue":"1","key":"3175_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1161\/hypertensionaha.115.05513","volume":"66","author":"LA Lipsitz","year":"2015","unstructured":"Lipsitz LA, Habtemariam D, Gagnon M et al (2015) Reexamining the effect of antihypertensive medications on falls in old age. Hypertension 66(1):183\u2013189. https:\/\/doi.org\/10.1161\/hypertensionaha.115.05513","journal-title":"Hypertension"},{"issue":"5","key":"3175_CR24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2125.2010.03613.x","volume":"69","author":"H Shuto","year":"2010","unstructured":"Shuto H, Imakyure O, Matsumoto J et al (2010) Medication use as a risk factor for inpatient falls in an acute care hospital: a case-crossover study. Br J Clin Pharmacol 69(5):535\u2013542. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03613.x","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3175_CR25","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/jgs.12205","volume":"61","author":"AKW Wong","year":"2013","unstructured":"Wong AKW, Lord SR, Sturnieks DL et al (2013) Angiotensin system blocking medications are associated with fewer falls over 12 months in community-dwelling older people. J Am Geriatr Soc 61(5):776\u2013781. https:\/\/doi.org\/10.1111\/jgs.12205","journal-title":"J Am Geriatr Soc"},{"key":"3175_CR26","first-page":"37","volume":"33","author":"M Callisaya","year":"2014","unstructured":"Callisaya M, Sharman J, Close J et al (2014) Greater daily defined dose of antihypertensive medication increases the risk of falls in older people - a population-based study. Australas J Ageing 33:37\u201337","journal-title":"Australas J Ageing"},{"issue":"5","key":"3175_CR27","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/ageing\/afq092","volume":"39","author":"J Gribbin","year":"2010","unstructured":"Gribbin J, Hubbard R, Gladman JRF et al (2010) Risk of falls associated with antihypertensive medication: population-based case-control study. Age Ageing 39(5):592\u2013597. https:\/\/doi.org\/10.1093\/ageing\/afq092","journal-title":"Age Ageing"},{"issue":"4","key":"3175_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3109\/02813439508996778","volume":"13","author":"H Luukinen","year":"1995","unstructured":"Luukinen H, Koski K, Laippala P et al (1995) Predictors for recurrent falls among the home-dwelling elderly. Scand J Prim Health Care 13(4):294\u2013299. https:\/\/doi.org\/10.3109\/02813439508996778","journal-title":"Scand J Prim Health Care"},{"issue":"3","key":"3175_CR29","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/s0011-393x(03)00023-7","volume":"64","author":"AA Fisher","year":"2003","unstructured":"Fisher AA, McLean AJ, Davis MW et al (2003) A multicenter, case-control study of the effects of antihypertensive therapy on orthostatic hypotension, postprandial hypotension, and falls in octo- and nonagenarians in residential care facilities. Current Therapeutic Research-Clinical and Experimental 64(3):206\u2013214. https:\/\/doi.org\/10.1016\/s0011-393x(03)00023-7","journal-title":"Current Therapeutic Research-Clinical and Experimental"},{"issue":"12","key":"3175_CR30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s40266-014-0225-x","volume":"31","author":"AC Ham","year":"2014","unstructured":"Ham AC, Swart KMA, Enneman AW et al (2014) Medication-related fall incidents in an older, ambulant population: The B-PROOF Study. Drugs Aging 31(12):917\u2013927. https:\/\/doi.org\/10.1007\/s40266-014-0225-x","journal-title":"Drugs Aging"},{"issue":"2","key":"3175_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/106002808501900212","volume":"19","author":"BG Wells","year":"1985","unstructured":"Wells BG, Middleton B, Lawrence G et al (1985) Factors associated with the elderly falling in intermediate care facilities. Drug Intell Clin Pharm 19(2):142\u2013145","journal-title":"Drug Intell Clin Pharm"},{"issue":"7\u20138","key":"3175_CR32","first-page":"539","volume":"17","author":"KG Sobel","year":"1983","unstructured":"Sobel KG, McCart GM (1983) Drug use and accidental falls in an intermediate care facility. Drug Intell Clin Pharm 17(7\u20138):539\u2013542","journal-title":"Drug Intell Clin Pharm"},{"key":"3175_CR33","doi-asserted-by":"publisher","unstructured":"de Vries M, Seppala LJ, Daams JG et al (2018) Fall-risk-increasing drugs: A systematic review and meta-analysis: I. Cardiovascular Drugs. J Am Med Dir Assoc 19 (4). https:\/\/doi.org\/10.1016\/j.jamda.2017.12.013","DOI":"10.1016\/j.jamda.2017.12.013"},{"issue":"10","key":"3175_CR34","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00198-013-2369-7","volume":"24","author":"DA Butt","year":"2013","unstructured":"Butt DA, Mamdani M, Austin PC et al (2013) The risk of falls on initiation of antihypertensive drugs in the elderly. Osteoporos Int 24(10):2649\u20132657. https:\/\/doi.org\/10.1007\/s00198-013-2369-7","journal-title":"Osteoporos Int"},{"key":"3175_CR35","doi-asserted-by":"publisher","unstructured":"Shimbo D, Bowling CB, Levitan EB et al (2016) Short-term risk of serious fall injuries in older adults initiating and intensifying treatment with antihypertensive medication. Circ Cardiovasc Qual\u00a0Outcomes 9 (3):222-+.\u00a0https:\/\/doi.org\/10.1161\/circoutcomes.115.002524","DOI":"10.1161\/circoutcomes.115.002524"},{"issue":"5","key":"3175_CR36","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/pds.3256","volume":"21","author":"SD Berry","year":"2012","unstructured":"Berry SD, Mittleman MA, Zhang Y et al (2012) New loop diuretic prescriptions may be an acute risk factor for falls in the nursing home. Pharmacoepidemiol Drug Saf 21(5):560\u2013563. https:\/\/doi.org\/10.1002\/pds.3256","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"3175_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5114\/fmpcr\/60614","volume":"18","author":"MS Kaminska","year":"2016","unstructured":"Kaminska MS, Brodowski J, Karakiewicz B (2016) The incidence of falls among geriatric outpatients in relation to the number and types of drugs taken. Family Medicine and Primary Care Review 18(2):123\u2013127. https:\/\/doi.org\/10.5114\/fmpcr\/60614","journal-title":"Family Medicine and Primary Care Review"},{"issue":"3","key":"3175_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1447-0594.2011.00783.x","volume":"12","author":"T Kojima","year":"2012","unstructured":"Kojima T, Akishita M, Nakamura T et al (2012) Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatr Gerontol Int 12(3):425\u2013430. https:\/\/doi.org\/10.1111\/j.1447-0594.2011.00783.x","journal-title":"Geriatr Gerontol Int"},{"issue":"5","key":"3175_CR39","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.cjca.2013.08.012","volume":"30","author":"TR Richards","year":"2014","unstructured":"Richards TR, Tobe SW (2014) Combining other antihypertensive drugs with beta-blockers in hypertension: A focus on safety and tolerability. Can J Cardiol 30(5):S42\u2013S46. https:\/\/doi.org\/10.1016\/j.cjca.2013.08.012","journal-title":"Can J Cardiol"},{"issue":"5","key":"3175_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40256-013-0033-4","volume":"13","author":"KC Ferdinand","year":"2013","unstructured":"Ferdinand KC, Nasser SA (2013) A review of the efficacy and tolerability of combination amlodipine\/valsartan in non-White patients with hypertension. Am J Cardiovasc Drugs 13(5):301\u2013313. https:\/\/doi.org\/10.1007\/s40256-013-0033-4","journal-title":"Am J Cardiovasc Drugs"},{"issue":"5","key":"3175_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.amjopharm.2011.08.002","volume":"9","author":"C Casteel","year":"2011","unstructured":"Casteel C, Blalock SJ, Ferreri S et al (2011) Implementation of a community pharmacy-based falls prevention program. American Journal of Geriatric Pharmacotherapy 9(5):310\u2013319. https:\/\/doi.org\/10.1016\/j.amjopharm.2011.08.002","journal-title":"American Journal of Geriatric Pharmacotherapy"},{"issue":"10","key":"3175_CR42","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40266-015-0296-3","volume":"32","author":"TS Dharmarajan","year":"2015","unstructured":"Dharmarajan TS, Dharmarajan L (2015) Tolerability of antihypertensive medications in older adults. Drugs Aging 32(10):773\u2013796. https:\/\/doi.org\/10.1007\/s40266-015-0296-3","journal-title":"Drugs Aging"},{"issue":"1","key":"3175_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0033-3506(95)80076-x","volume":"109","author":"H Luukinen","year":"1995","unstructured":"Luukinen H, Koski K, Laippala P et al (1995) Risk factors for recurrent falls in the elderly in long-term institutional care. Public Health 109(1):57\u201365. https:\/\/doi.org\/10.1016\/s0033-3506(95)80076-x","journal-title":"Public Health"},{"key":"3175_CR44","doi-asserted-by":"publisher","unstructured":"Xu R, Wang Q (2014) Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection. BMC Bioinformatics 15. https:\/\/doi.org\/10.1186\/1471-2105-15-17","DOI":"10.1186\/1471-2105-15-17"},{"issue":"5","key":"3175_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2165\/11599460-000000000-00000","volume":"29","author":"AR Huang","year":"2012","unstructured":"Huang AR, Mallet L, Rochefort CM et al (2012) Medication-related falls in the elderly causative factors and preventive strategies. Drugs Aging 29(5):359\u2013376. https:\/\/doi.org\/10.2165\/11599460-000000000-00000","journal-title":"Drugs Aging"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03175-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03175-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03175-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T13:09:01Z","timestamp":1626095341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03175-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3175"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03175-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors have seen and approved the submission of this version of the manuscript and took full responsibility.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}